Bakhu Holdings, Corp. Share Price

Equities

BKUH

US0575862083

Healthcare Facilities & Services

Market Closed - OTC Markets 14:30:05 17/07/2024 BST 5-day change 1st Jan Change
0.37 USD 0.00% Intraday chart for Bakhu Holdings, Corp. -7.50% +270.00%
Sales 2022 - Sales 2023 - Capitalization 298M 23.07B
Net income 2022 -20M -1.55B Net income 2023 -10M -773M EV / Sales 2022 -
Net Debt 2022 6.36M 492M Net Debt 2023 6.74M 521M EV / Sales 2023 -
P/E ratio 2022
-15.8 x
P/E ratio 2023
-28.9 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 33.87%
More Fundamentals * Estimated data
Dynamic Chart
1 week-7.50%
Current month-7.50%
1 month-7.50%
3 months+48.00%
6 months+270.00%
Current year+270.00%
More quotes
1 week
0.37
Extreme 0.37
0.37
1 month
0.37
Extreme 0.37
0.40
Current year
0.11
Extreme 0.11
0.40
1 year
0.01
Extreme 0.005
1.00
3 years
0.00
Extreme 0.0011
7.99
5 years
0.00
Extreme 0.0011
14.00
10 years
0.00
Extreme 0.0011
188.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 51 05/12/21
Chief Tech/Sci/R&D Officer 55 02/08/12
Director/Board Member 29 02/08/12
Members of the board TitleAgeSince
Director of Finance/CFO 51 05/12/21
Chairman 63 02-26
Chief Tech/Sci/R&D Officer 55 02/08/12
More insiders
Date Price Change Volume
17/07/24 0.37 0.00% 2,010

Delayed Quote OTC Markets, July 17, 2024 at 02:30 pm

More quotes
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
More about the company